PLB-985Homo sapiens (Human)Cancer cell line

Also known as: PLB985, PLB 985

🤖 AI SummaryBased on 7 publications

Quick Overview

Human myeloid leukemia cell line with applications in CGD research.

Detailed Summary

PLB-985 is a human myeloid leukemia cell line derived from a female patient with relapsed myeloid leukemia. It is widely used in research on Chronic Granulomatous Disease (CGD), particularly in studying the gp91phox and p47phox genes. The cell line is capable of differentiating into granulocytic and monocytic lineages, making it a valuable model for investigating the molecular mechanisms of CGD. PLB-985 has been utilized in gene targeting studies to disrupt the X-linked gp91phox gene, enabling the development of in vitro models for CGD. Additionally, it has been employed in CRISPR/Cas9-mediated gene therapy vector development for p47phox-deficient CGD. The cell line's ability to generate reactive oxygen species (ROS) upon differentiation makes it a key tool for studying respiratory burst activity in phagocytes.

Research Applications

Chronic Granulomatous Disease (CGD) researchGene targeting studiesCRISPR/Cas9-mediated gene therapy developmentRespiratory burst activity analysis

Key Characteristics

Capable of granulocytic and monocytic differentiationUsed in studying gp91phox and p47phox gene mutationsModel for X-linked and autosomal recessive CGDSupports in vitro gene therapy vector testing
Generated on 6/18/2025

Basic Information

Database IDCVCL_2162
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age35
Age CategoryAdult
SexFemale
Racecaucasian

Disease Information

DiseaseAcute myeloid leukemia
LineageMyeloid
SubtypeAcute Myeloid Leukemia
OncoTree CodeAML

DepMap Information

Source TypeAcademic lab
Source IDACH-000034_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNRASp.Gln61Leu (c.182A>T)Unspecified-PubMed=26214590
MutationSimpleCDKN2Ap.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T)Homozygous-from parent cell line HL-60
Gene deletionTP53-Homozygous2 out of 3 copiesfrom parent cell line HL-60

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
13,14
D13S317
8,11
D16S539
11
D18S51
14,15
D19S433
14
D21S11
29,30
D2S1338
17
D3S1358
16
D5S818
12
D7S820
11,12
D8S1179
12
FGA
22,24
Penta D
10,11
Penta E
13,14
TH01
7,8
TPOX
8,11
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Anti-leukemic properties of histamine in monocytic leukemia: the role of NOX2.

Nilsson J.A., Stahlberg A., Thoren F.B., Hellstrand K., Martner A.

Front. Oncol. 8:218.1-218.12(2018).

CRISPR/Cas9-generated p47(phox)-deficient cell line for chronic granulomatous disease gene therapy vector development.

Wrona D., Siler U., Reichenbach J.

Sci. Rep. 7:44187-44187(2017).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Check your cultures! A list of cross-contaminated or misidentified cell lines.

Freshney R.I.

Int. J. Cancer 127:1-8(2010).

False leukemia-lymphoma cell lines: an update on over 500 cell lines.

Drexler H.G., Dirks W.G., Matsuo Y., MacLeod R.A.F.

Leukemia 17:416-426(2003).

Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox.

Zhen L., King A.A.J., Xiao Y.-H., Chanock S.J., Orkin S.H., Dinauer M.C.

Proc. Natl. Acad. Sci. U.S.A. 90:9832-9836(1993).

Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity.

Tucker K.A., Lilly M.B., Heck L. Jr., Rado T.A.

Blood 70:372-378(1987).